Valpatasvir/sofobuvir; a panacea for HCV? By: Takako Schaninger, MDAssociate Professor of Medicine | UK HealthCare This month, the FDA is expected to approve a new hepatitis C virus (HCV) drug. The once-daily, single-tablet, fixed-dose coformulation of velpatasvir and...
Provider Case Conference Resources Presentation Resources For more information and/or case presentation materials, please click on the corresponding tab below. AllSCHPTISVICCVCCC HIV PrEP Telehealth Initiative Case Submission Form (.doc) SVICC Case Submission Form ...
Provider Resources It is now recognized that outreach, testing, and linkage to care; case management; behavioral and oral health services; and patient advocacy are as essential to providing high quality HIV care as antiretroviral management, health maintenance, and...
HIV Prevention During a Pandemic: Adapting to a New Normal – Provider Resources for Routine HIV Testing The Centers for Disease Control and Prevention (CDC) estimates that there are approximately 1.2 million people with HIV (PWH) in the United States (US)....
Keeping Prevention Standard During a Pandemic: Provider Resources for Routine HIV Testing By: RAPID Resource Program – University of Miami The Centers for Disease Control and Prevention (CDC) estimate that there are approximately 160,000 people living in the...
